Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 866 of 6351
-
Radiation boost may tame untreatable kidney cancer
Disease control Recruiting nowThis phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended f…
Phase 2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can housing and counseling curb gun violence? new haven study aims to find out
Prevention Recruiting nowThe overall objective of this study is to implement and test a strengths-based, community-driven intervention to reduce gun violence by (1) improving housing stability through providing financial assistance coupled with comprehensive financial education for the re-entry populatio…
Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
New hope for kids with rare immune disease: drug targets root cause
Disease control OngoingThis is a 2-part, prospective, open-label, single arm, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx), and efficacy of leniolisib in at least 15 pediatric patients (aged 4 to 11 years) with activated phosphoinositide 3-kinase…
Phase 3 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for rare gut cancers: triple-drug combo shows promise
Disease control Recruiting nowTo explore the safety and efficacy of Surufatinib and Sintilimab in Combination With Capecitabine in Patients With Previously Treated Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma : a Single-arm, a Single-center , Phase 2 Trial. Meanwhile, Exploring the maxim…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New combo aims to wipe out prostate tumors before surgery
Disease control OngoingPhase 2 open-label, single-arm clinical trial evaluating the efficacy and safety of neoadjuvant olaparib + LHRH agonist administered for 6 months prior to radical prostatectomy (RP) in men with unfavorable intermediate-risk or high-risk localized prostate cancer. All patients mus…
Phase 2 • Sponsor: Rana McKay, MD • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can cutting carbs curb knee pain? a diet trial puts it to the test
Symptom relief Recruiting nowKnee osteoarthritis (OA) is the most prevalent form of arthritis, a significant cause of disability in the U.S. With an aging population and the rise in obesity rates, the prevalence of knee OA is expected to climb, significantly reducing quality of life (QOL) for those suffering…
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Family history lung cancer screening study launches in hong kong
Knowledge-focused Recruiting nowLung cancer can be detected via screening of high-risk individuals, i.e current or ex-heavy smokers, with low-dose computer tomography (LDCT) of thorax. The National Lung Screening Trial in US and the NELSON trial in Europe demonstrated reduction in lung cancer mortality with LDC…
Sponsor: The University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Walking workouts may sharpen the MS brain — a trial puts it to the test
Disease control OngoingThis study is a randomized controlled trial (RCT) that compares the effects of two different 12-month aerobic walking exercise programs on cognitive processing speed (CPS), brain MRI, and other functional outcomes in 32 adults with multiple sclerosis (MS) who are able to walk wit…
Phase 1 • Sponsor: Kessler Foundation • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Implanted sensors may foresee heart failure crises
Knowledge-focused OngoingThis is a prospective, multicenter, observational patient registry designed to evaluate the association between changes in device-based sensor parameters and heart failure (HF) aggravation in patients implanted with Boston Scientific implantable cardioverter-defibrillators (ICDs)…
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Pharmacies vs. street: does regulated cannabis improve health?
Disease control OngoingThe randomised controlled study on regulated cannabis access in pharmacies in Basel aims to investigate the effects of regulated cannabis access on consumption behaviour and mental and physical health in comparison to the illegal market.
Sponsor: Health Department of the Canton of Basel-Stadt • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Frozen poop pills could tame ulcerative colitis
Disease control OngoingFRESCO is a randomized, longitudinal, prospective, three arm, multicentre, double blind study to determine safety and efficacy of repeated faecal microbiota transplantation (FMT) or faecal microbiota filtrate transplantation (FMFT) compared to placebo using oral, frozen capsules …
Phase 3 • Sponsor: Andreas Stallmach • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New chemo combo tested to extend life in Hard-to-Treat stomach and esophageal cancers
Disease control Recruiting nowThis phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) with or without nivolumab to the effect of modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) with or without nivolumab for the treat…
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug combo aims to wipe out CLL cells, guided by a simple blood test
Disease control OngoingThis phase II trial studies how well pirtobrutinib and venetoclax work in treating patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. This study also seeks to adopt a blood test which shows a small number of cancer cells in the body after cancer treatment c…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug ecopipam shows promise for Tourette's tics in Late-Stage trial
Disease control CompletedThis Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability of ecopipam tablets in children, adolescents and adults in the treatment of Tourette's Disorder (TD). The study includes an open-label period followed by a double-blind, placebo-controll…
Phase 3 • Sponsor: Emalex Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New blood test aims to slash unnecessary antibiotics in ER lung infections
Disease control Recruiting nowThis is a Prospective, multi-center study enrolling adults subjects presented to the ED/Urgent care, with symptoms consistent with lower respiratory infection (LRTI). The reason of this study is to demonstrate the MeMed BV can help clinicians make decisions about using antibioti…
Sponsor: MeMed Diagnostics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Engineered cells take on tough blood cancer in first human trial
Disease control Recruiting nowFirst in humans, exploratory, open-label, single-arm, multicentre, non-competitive, dose escalation study to assess the safety and efficacy of CD1a-CAR T therapy in patients with relapsed/refractory (R/R) T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LL)
Phase 1 • Sponsor: OneChain Immunotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Sound waves take on tough pancreatic cancer
Disease control OngoingThe purpose of this study is to evaluate the safety and efficacy of standard chemotherapy with or without a novel High Intensity Focused Ultrasound system (Code: Suizenji) in patients with unresectable pancreatic cancer who are refractory or intolerant to first-line chemotherapy.
Sponsor: SONIRE Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Timing of brain radiation could change outcomes for cancer patients
Disease control Recruiting nowThis is a phase III randomized trial with the aim to compare preoperative HSRS to postoperative HSRS in patients with large at least one BMs from solid tumors suitable for surgical resection.
Sponsor: Istituto Clinico Humanitas • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Nose spray could block COVID spread in homes
Prevention CompletedCoronavirus-induced disease 2019 (COVID-19) is an infection caused by a virus whose full name is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This is a new and rapidly-spreading infectious disease which carries a significant risk of death, has brought massive eco…
Phase 2/3 • Sponsor: Murdoch Childrens Research Institute • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Could less radiation be enough? new trial aims to reduce side effects for throat cancer patients
Disease control OngoingThis is a single-arm, phase II study to establish the safety of reducing radiation dose in selected HPV-Associated OPSCC patients receiving adjuvant radiation after TORS and neck dissection. This protocol also allows for sparing of the primary resection bed, in appropriate patien…
Phase 2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC